Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Immunology Letters|September 24, 2019
IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progressionTohid Gharibi, Arezoo Hosseini, Faroogh Marofi, et al.
Breast Cancer (Tokyo, Japan)|September 5, 2020
Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs)Sajad Yaghoubi, Tohid Gharibi, Mohammad Hossein Karimi, et al.
BMC Research Notes|December 30, 2020
Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis diseaseArezoo Hosseini, Zohreh Babaloo, Tohid Gharibi, et al.
International Immunopharmacology|April 20, 2023
STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balanceTohid Gharibi, Nesa Barpour, Arezoo Hosseini, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 10, 2021
COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic MethodsFaroogh Marofi, Ramyar Azizi, Roza Motavalli, et al.
Journal of Cellular Physiology|June 20, 2019
Potential drugs used in the antibody-drug conjugate (ADC) architecture for cancer therapySajad Yaghoubi, Mohammad Hossein Karimi, Majid Lotfinia, et al.
Journal of Cellular Physiology|November 28, 2018
Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successesMeghdad Abdollahpour-Alitappeh, Majid Lotfinia, Tohid Gharibi, et al.
Biotechnology and Applied Biochemistry|March 31, 2021
Under hypoxic conditions, MSCs affect the expression and methylation level of survival-related genes in ALL independent of apoptosis pathways in vitroFaroogh Marofi, Navid Shomali, Laith A Younus, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 23, 2023
Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancerZohreh Najminejad, Fatemeh Dehghani, Yousef Mirzaei, et al.
Pageof 3